Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Eterna Therapeutics Inc
Swot
Eterna Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Eterna Therapeutics Inc has 5 Strengths, 13 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(5)
Weakness
(13)
Opportunity
(5)
Threats
(1)
Others
(0)
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter
New 52 week low today
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Biggest Price Losers from Open
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Near 52 Week Low
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
Red Flags: Weakening Technicals and Share Price Decline
